nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—stomach cancer—liver cancer	0.204	0.372	CtDrD
Docetaxel—pancreatic cancer—liver cancer	0.19	0.347	CtDrD
Docetaxel—lung cancer—liver cancer	0.153	0.28	CtDrD
Docetaxel—ABCC10—Doxorubicin—liver cancer	0.044	0.187	CbGbCtD
Docetaxel—ABCC1—Epirubicin—liver cancer	0.032	0.136	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—liver cancer	0.0239	0.101	CbGbCtD
Docetaxel—ABCC2—Sorafenib—liver cancer	0.0207	0.0879	CbGbCtD
Docetaxel—ABCG2—Sorafenib—liver cancer	0.0188	0.0795	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—liver cancer	0.017	0.0721	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0139	0.0587	CbGbCtD
Docetaxel—CYP3A7—Sorafenib—liver cancer	0.0139	0.0587	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—liver cancer	0.0126	0.0534	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—liver cancer	0.0114	0.0482	CbGbCtD
Docetaxel—ABCC2—bile canaliculus—liver cancer	0.0107	0.364	CbGeAlD
Docetaxel—CYP3A5—Sorafenib—liver cancer	0.0104	0.044	CbGbCtD
Docetaxel—ABCB1—Sorafenib—liver cancer	0.00676	0.0287	CbGbCtD
Docetaxel—ABCB1—Doxorubicin—liver cancer	0.0041	0.0174	CbGbCtD
Docetaxel—CYP3A4—Sorafenib—liver cancer	0.00405	0.0172	CbGbCtD
Docetaxel—ABCC2—bile duct—liver cancer	0.00335	0.114	CbGeAlD
Docetaxel—ABCC2—bile—liver cancer	0.00257	0.0873	CbGeAlD
Docetaxel—KIF11—embryo—liver cancer	0.00256	0.0868	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—liver cancer	0.00246	0.0104	CbGbCtD
Docetaxel—MAP4—embryo—liver cancer	0.00118	0.04	CbGeAlD
Docetaxel—MAP2—embryo—liver cancer	0.000928	0.0315	CbGeAlD
Docetaxel—NR1I2—liver—liver cancer	0.000833	0.0283	CbGeAlD
Docetaxel—TUBB4A—embryo—liver cancer	0.000717	0.0244	CbGeAlD
Docetaxel—TUBB4B—embryo—liver cancer	0.00056	0.019	CbGeAlD
Docetaxel—MAP4—liver—liver cancer	0.000545	0.0185	CbGeAlD
Docetaxel—EGFR—liver—liver cancer	0.00049	0.0166	CbGeAlD
Docetaxel—SLCO1B3—liver—liver cancer	0.000477	0.0162	CbGeAlD
Docetaxel—MAP2—liver—liver cancer	0.000429	0.0146	CbGeAlD
Docetaxel—CYP3A7—liver—liver cancer	0.000403	0.0137	CbGeAlD
Docetaxel—SLC22A7—liver—liver cancer	0.000371	0.0126	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—liver cancer	0.000342	0.0116	CbGeAlD
Docetaxel—TUBB4A—liver—liver cancer	0.000332	0.0113	CbGeAlD
Docetaxel—TUBB—liver—liver cancer	0.000303	0.0103	CbGeAlD
Docetaxel—TUBB2A—liver—liver cancer	0.000302	0.0102	CbGeAlD
Docetaxel—TUBB6—liver—liver cancer	0.000298	0.0101	CbGeAlD
Docetaxel—ABCC10—liver—liver cancer	0.000261	0.00885	CbGeAlD
Docetaxel—TUBB4B—liver—liver cancer	0.000259	0.00879	CbGeAlD
Docetaxel—ABCC2—liver—liver cancer	0.000209	0.00711	CbGeAlD
Docetaxel—CYP1B1—liver—liver cancer	0.000205	0.00696	CbGeAlD
Docetaxel—ABCC1—liver—liver cancer	0.000184	0.00626	CbGeAlD
Docetaxel—ABCB1—embryo—liver cancer	0.000163	0.00552	CbGeAlD
Docetaxel—ABCG2—liver—liver cancer	0.000153	0.00518	CbGeAlD
Docetaxel—CYP3A5—liver—liver cancer	0.000142	0.00481	CbGeAlD
Docetaxel—CYP3A4—liver—liver cancer	0.000106	0.00361	CbGeAlD
Docetaxel—Sepsis—Doxorubicin—liver cancer	0.000103	0.00103	CcSEcCtD
Docetaxel—Cardiac failure congestive—Epirubicin—liver cancer	0.000103	0.00103	CcSEcCtD
Docetaxel—Gastrointestinal pain—Sorafenib—liver cancer	0.000101	0.00101	CcSEcCtD
Docetaxel—Phlebitis—Doxorubicin—liver cancer	0.0001	0.001	CcSEcCtD
Docetaxel—Hot flush—Epirubicin—liver cancer	9.95e-05	0.000998	CcSEcCtD
Docetaxel—Thrombophlebitis—Doxorubicin—liver cancer	9.95e-05	0.000997	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	9.9e-05	0.000993	CcSEcCtD
Docetaxel—Menopausal symptoms—Epirubicin—liver cancer	9.86e-05	0.000989	CcSEcCtD
Docetaxel—Body temperature increased—Sorafenib—liver cancer	9.78e-05	0.000981	CcSEcCtD
Docetaxel—Abdominal pain—Sorafenib—liver cancer	9.78e-05	0.000981	CcSEcCtD
Docetaxel—Renal impairment—Epirubicin—liver cancer	9.78e-05	0.00098	CcSEcCtD
Docetaxel—Dermatitis bullous—Epirubicin—liver cancer	9.74e-05	0.000976	CcSEcCtD
Docetaxel—Hepatic failure—Doxorubicin—liver cancer	9.58e-05	0.000961	CcSEcCtD
Docetaxel—Cardiac failure—Epirubicin—liver cancer	9.54e-05	0.000956	CcSEcCtD
Docetaxel—Lethargy—Epirubicin—liver cancer	9.5e-05	0.000952	CcSEcCtD
Docetaxel—Cardiac failure congestive—Doxorubicin—liver cancer	9.5e-05	0.000952	CcSEcCtD
Docetaxel—Hyponatraemia—Epirubicin—liver cancer	9.34e-05	0.000937	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Epirubicin—liver cancer	9.31e-05	0.000933	CcSEcCtD
Docetaxel—Pain in extremity—Epirubicin—liver cancer	9.31e-05	0.000933	CcSEcCtD
Docetaxel—Hot flush—Doxorubicin—liver cancer	9.21e-05	0.000923	CcSEcCtD
Docetaxel—Migraine—Epirubicin—liver cancer	9.16e-05	0.000918	CcSEcCtD
Docetaxel—Menopausal symptoms—Doxorubicin—liver cancer	9.13e-05	0.000915	CcSEcCtD
Docetaxel—Hypersensitivity—Sorafenib—liver cancer	9.12e-05	0.000914	CcSEcCtD
Docetaxel—Renal impairment—Doxorubicin—liver cancer	9.05e-05	0.000907	CcSEcCtD
Docetaxel—Dermatitis bullous—Doxorubicin—liver cancer	9.01e-05	0.000903	CcSEcCtD
Docetaxel—Asthenia—Sorafenib—liver cancer	8.88e-05	0.00089	CcSEcCtD
Docetaxel—Cardiac failure—Doxorubicin—liver cancer	8.82e-05	0.000885	CcSEcCtD
Docetaxel—Lethargy—Doxorubicin—liver cancer	8.79e-05	0.000881	CcSEcCtD
Docetaxel—Pruritus—Sorafenib—liver cancer	8.76e-05	0.000878	CcSEcCtD
Docetaxel—Ataxia—Epirubicin—liver cancer	8.75e-05	0.000877	CcSEcCtD
Docetaxel—Dehydration—Epirubicin—liver cancer	8.66e-05	0.000868	CcSEcCtD
Docetaxel—Hyponatraemia—Doxorubicin—liver cancer	8.65e-05	0.000867	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	8.61e-05	0.000863	CcSEcCtD
Docetaxel—Pain in extremity—Doxorubicin—liver cancer	8.61e-05	0.000863	CcSEcCtD
Docetaxel—Liver function test abnormal—Epirubicin—liver cancer	8.59e-05	0.000862	CcSEcCtD
Docetaxel—Dry skin—Epirubicin—liver cancer	8.53e-05	0.000855	CcSEcCtD
Docetaxel—Abdominal pain upper—Epirubicin—liver cancer	8.5e-05	0.000852	CcSEcCtD
Docetaxel—Orthostatic hypotension—Epirubicin—liver cancer	8.5e-05	0.000852	CcSEcCtD
Docetaxel—Migraine—Doxorubicin—liver cancer	8.48e-05	0.00085	CcSEcCtD
Docetaxel—Diarrhoea—Sorafenib—liver cancer	8.47e-05	0.000849	CcSEcCtD
Docetaxel—Breast disorder—Epirubicin—liver cancer	8.41e-05	0.000843	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Epirubicin—liver cancer	8.38e-05	0.00084	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Epirubicin—liver cancer	8.38e-05	0.00084	CcSEcCtD
Docetaxel—Nasopharyngitis—Epirubicin—liver cancer	8.32e-05	0.000834	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Epirubicin—liver cancer	8.21e-05	0.000823	CcSEcCtD
Docetaxel—Dizziness—Sorafenib—liver cancer	8.18e-05	0.000821	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—liver cancer	8.1e-05	0.000812	CcSEcCtD
Docetaxel—Dysphagia—Epirubicin—liver cancer	8.04e-05	0.000806	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—liver cancer	8.01e-05	0.000803	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—liver cancer	7.95e-05	0.000797	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—liver cancer	7.89e-05	0.000791	CcSEcCtD
Docetaxel—Vomiting—Sorafenib—liver cancer	7.87e-05	0.000789	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—liver cancer	7.87e-05	0.000789	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—liver cancer	7.87e-05	0.000789	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—liver cancer	7.84e-05	0.000786	CcSEcCtD
Docetaxel—Rash—Sorafenib—liver cancer	7.8e-05	0.000782	CcSEcCtD
Docetaxel—Dermatitis—Sorafenib—liver cancer	7.8e-05	0.000782	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—liver cancer	7.78e-05	0.00078	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—liver cancer	7.75e-05	0.000777	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—liver cancer	7.75e-05	0.000777	CcSEcCtD
Docetaxel—Headache—Sorafenib—liver cancer	7.75e-05	0.000777	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—liver cancer	7.7e-05	0.000772	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—liver cancer	7.64e-05	0.000766	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—liver cancer	7.59e-05	0.000761	CcSEcCtD
Docetaxel—ABCB1—liver—liver cancer	7.53e-05	0.00256	CbGeAlD
Docetaxel—Neutropenia—Epirubicin—liver cancer	7.52e-05	0.000754	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—liver cancer	7.44e-05	0.000746	CcSEcCtD
Docetaxel—Nausea—Sorafenib—liver cancer	7.35e-05	0.000737	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—liver cancer	7.32e-05	0.000734	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—liver cancer	7.28e-05	0.00073	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—liver cancer	7.25e-05	0.000727	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—liver cancer	7.21e-05	0.000723	CcSEcCtD
Docetaxel—Infestation—Epirubicin—liver cancer	7.17e-05	0.000719	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—liver cancer	7.17e-05	0.000719	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—liver cancer	7.11e-05	0.000713	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—liver cancer	7.07e-05	0.000709	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—liver cancer	7.05e-05	0.000707	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—liver cancer	7.03e-05	0.000705	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—liver cancer	6.99e-05	0.000701	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—liver cancer	6.99e-05	0.000701	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—liver cancer	6.97e-05	0.000699	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—liver cancer	6.96e-05	0.000698	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—liver cancer	6.78e-05	0.00068	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—liver cancer	6.77e-05	0.000679	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—liver cancer	6.76e-05	0.000678	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—liver cancer	6.73e-05	0.000675	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—liver cancer	6.69e-05	0.000671	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—liver cancer	6.67e-05	0.000669	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—liver cancer	6.64e-05	0.000665	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—liver cancer	6.64e-05	0.000665	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—liver cancer	6.58e-05	0.00066	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—liver cancer	6.52e-05	0.000654	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—liver cancer	6.5e-05	0.000652	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—liver cancer	6.47e-05	0.000649	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—liver cancer	6.47e-05	0.000649	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—liver cancer	6.47e-05	0.000649	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—liver cancer	6.45e-05	0.000647	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—liver cancer	6.45e-05	0.000647	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—liver cancer	6.44e-05	0.000646	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—liver cancer	6.44e-05	0.000646	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—liver cancer	6.41e-05	0.000642	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—liver cancer	6.39e-05	0.000641	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—liver cancer	6.36e-05	0.000638	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—liver cancer	6.34e-05	0.000636	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—liver cancer	6.33e-05	0.000634	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—liver cancer	6.31e-05	0.000633	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—liver cancer	6.28e-05	0.000629	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—liver cancer	6.26e-05	0.000628	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—liver cancer	6.2e-05	0.000622	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—liver cancer	6.19e-05	0.000621	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—liver cancer	6.09e-05	0.00061	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—liver cancer	6.02e-05	0.000603	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—liver cancer	5.99e-05	0.0006	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—liver cancer	5.98e-05	0.000599	CcSEcCtD
Docetaxel—Flushing—Epirubicin—liver cancer	5.98e-05	0.000599	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—liver cancer	5.97e-05	0.000599	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—liver cancer	5.96e-05	0.000597	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—liver cancer	5.96e-05	0.000597	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—liver cancer	5.93e-05	0.000594	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—liver cancer	5.91e-05	0.000593	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—liver cancer	5.88e-05	0.00059	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—liver cancer	5.87e-05	0.000588	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—liver cancer	5.85e-05	0.000587	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—liver cancer	5.84e-05	0.000586	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—liver cancer	5.84e-05	0.000586	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—liver cancer	5.82e-05	0.000583	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—liver cancer	5.8e-05	0.000582	CcSEcCtD
Docetaxel—Chills—Epirubicin—liver cancer	5.78e-05	0.000579	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—liver cancer	5.75e-05	0.000577	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—liver cancer	5.74e-05	0.000576	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—liver cancer	5.69e-05	0.00057	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—liver cancer	5.64e-05	0.000566	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—liver cancer	5.63e-05	0.000565	CcSEcCtD
Docetaxel—Erythema—Epirubicin—liver cancer	5.6e-05	0.000562	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—liver cancer	5.6e-05	0.000562	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—liver cancer	5.57e-05	0.000558	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—liver cancer	5.53e-05	0.000554	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—liver cancer	5.53e-05	0.000554	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—liver cancer	5.49e-05	0.00055	CcSEcCtD
Docetaxel—Back pain—Epirubicin—liver cancer	5.42e-05	0.000544	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—liver cancer	5.4e-05	0.000542	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—liver cancer	5.39e-05	0.00054	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—liver cancer	5.38e-05	0.00054	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—liver cancer	5.37e-05	0.000538	CcSEcCtD
Docetaxel—Chills—Doxorubicin—liver cancer	5.35e-05	0.000536	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—liver cancer	5.32e-05	0.000534	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—liver cancer	5.26e-05	0.000528	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—liver cancer	5.22e-05	0.000523	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—liver cancer	5.19e-05	0.00052	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—liver cancer	5.19e-05	0.00052	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—liver cancer	5.18e-05	0.000519	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—liver cancer	5.08e-05	0.000509	CcSEcCtD
Docetaxel—Syncope—Epirubicin—liver cancer	5.03e-05	0.000504	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—liver cancer	5.02e-05	0.000503	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—liver cancer	5.02e-05	0.000503	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—liver cancer	4.99e-05	0.0005	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—liver cancer	4.95e-05	0.000497	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—liver cancer	4.93e-05	0.000494	CcSEcCtD
Docetaxel—Cough—Epirubicin—liver cancer	4.89e-05	0.00049	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—liver cancer	4.86e-05	0.000487	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—liver cancer	4.84e-05	0.000485	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—liver cancer	4.79e-05	0.000481	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—liver cancer	4.77e-05	0.000478	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—liver cancer	4.77e-05	0.000478	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—liver cancer	4.77e-05	0.000478	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	4.74e-05	0.000475	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—liver cancer	4.67e-05	0.000468	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—liver cancer	4.65e-05	0.000466	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—liver cancer	4.64e-05	0.000465	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—liver cancer	4.61e-05	0.000462	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—liver cancer	4.58e-05	0.000459	CcSEcCtD
Docetaxel—Oedema—Epirubicin—liver cancer	4.57e-05	0.000459	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—liver cancer	4.57e-05	0.000459	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—liver cancer	4.56e-05	0.000457	CcSEcCtD
Docetaxel—Infection—Epirubicin—liver cancer	4.54e-05	0.000456	CcSEcCtD
Docetaxel—Cough—Doxorubicin—liver cancer	4.53e-05	0.000454	CcSEcCtD
Docetaxel—Shock—Epirubicin—liver cancer	4.5e-05	0.000451	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—liver cancer	4.49e-05	0.000451	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—liver cancer	4.49e-05	0.00045	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—liver cancer	4.48e-05	0.000449	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—liver cancer	4.48e-05	0.000449	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—liver cancer	4.46e-05	0.000448	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—liver cancer	4.44e-05	0.000445	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—liver cancer	4.42e-05	0.000443	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—liver cancer	4.42e-05	0.000443	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—liver cancer	4.42e-05	0.000443	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	4.38e-05	0.00044	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—liver cancer	4.36e-05	0.000437	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—liver cancer	4.32e-05	0.000433	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—liver cancer	4.27e-05	0.000429	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—liver cancer	4.27e-05	0.000428	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—liver cancer	4.23e-05	0.000424	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—liver cancer	4.23e-05	0.000424	CcSEcCtD
Docetaxel—Infection—Doxorubicin—liver cancer	4.2e-05	0.000422	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—liver cancer	4.17e-05	0.000418	CcSEcCtD
Docetaxel—Shock—Doxorubicin—liver cancer	4.16e-05	0.000417	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—liver cancer	4.15e-05	0.000416	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—liver cancer	4.14e-05	0.000415	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—liver cancer	4.14e-05	0.000415	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—liver cancer	4.13e-05	0.000414	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—liver cancer	4.11e-05	0.000412	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—liver cancer	4.11e-05	0.000412	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—liver cancer	4.08e-05	0.000409	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—liver cancer	4.07e-05	0.000408	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—liver cancer	4.03e-05	0.000405	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—liver cancer	4.03e-05	0.000404	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—liver cancer	3.98e-05	0.000399	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—liver cancer	3.95e-05	0.000397	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—liver cancer	3.95e-05	0.000396	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—liver cancer	3.94e-05	0.000395	CcSEcCtD
Docetaxel—Pain—Epirubicin—liver cancer	3.91e-05	0.000392	CcSEcCtD
Docetaxel—Constipation—Epirubicin—liver cancer	3.91e-05	0.000392	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—liver cancer	3.86e-05	0.000387	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—liver cancer	3.83e-05	0.000384	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—liver cancer	3.8e-05	0.000381	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—liver cancer	3.77e-05	0.000378	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—liver cancer	3.77e-05	0.000378	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—liver cancer	3.76e-05	0.000377	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—liver cancer	3.74e-05	0.000375	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—liver cancer	3.73e-05	0.000374	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—liver cancer	3.68e-05	0.000369	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—liver cancer	3.65e-05	0.000366	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—liver cancer	3.65e-05	0.000366	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—liver cancer	3.62e-05	0.000363	CcSEcCtD
Docetaxel—Pain—Doxorubicin—liver cancer	3.62e-05	0.000363	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—liver cancer	3.62e-05	0.000363	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—liver cancer	3.62e-05	0.000363	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—liver cancer	3.49e-05	0.00035	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—liver cancer	3.46e-05	0.000347	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—liver cancer	3.37e-05	0.000338	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—liver cancer	3.35e-05	0.000335	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—liver cancer	3.35e-05	0.000335	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—liver cancer	3.28e-05	0.000329	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—liver cancer	3.24e-05	0.000324	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—liver cancer	3.13e-05	0.000314	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—liver cancer	3.12e-05	0.000313	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—liver cancer	3.04e-05	0.000304	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—liver cancer	3.02e-05	0.000303	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—liver cancer	2.99e-05	0.0003	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—liver cancer	2.91e-05	0.000292	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—liver cancer	2.9e-05	0.00029	CcSEcCtD
Docetaxel—Rash—Epirubicin—liver cancer	2.88e-05	0.000289	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—liver cancer	2.88e-05	0.000289	CcSEcCtD
Docetaxel—Headache—Epirubicin—liver cancer	2.87e-05	0.000287	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—liver cancer	2.8e-05	0.000281	CcSEcCtD
Docetaxel—Nausea—Epirubicin—liver cancer	2.72e-05	0.000272	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—liver cancer	2.69e-05	0.00027	CcSEcCtD
Docetaxel—Rash—Doxorubicin—liver cancer	2.67e-05	0.000268	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—liver cancer	2.67e-05	0.000267	CcSEcCtD
Docetaxel—Headache—Doxorubicin—liver cancer	2.65e-05	0.000266	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—liver cancer	2.51e-05	0.000252	CcSEcCtD
Docetaxel—ABCC1—Metabolism—CYP1A1—liver cancer	3.09e-06	3.54e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HMOX1—liver cancer	3.08e-06	3.53e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HMOX1—liver cancer	3.06e-06	3.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALDOB—liver cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—liver cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CD—liver cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A1—liver cancer	2.99e-06	3.42e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—liver cancer	2.97e-06	3.4e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PSMA4—liver cancer	2.97e-06	3.4e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PSMD10—liver cancer	2.97e-06	3.4e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—liver cancer	2.96e-06	3.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—liver cancer	2.94e-06	3.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—liver cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.9e-06	3.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—liver cancer	2.89e-06	3.31e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GOT2—liver cancer	2.89e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—liver cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CRABP1—liver cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCE—liver cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—liver cancer	2.87e-06	3.28e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—liver cancer	2.85e-06	3.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CD—liver cancer	2.84e-06	3.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARA—liver cancer	2.83e-06	3.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.8e-06	3.2e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—liver cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARA—liver cancer	2.74e-06	3.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—liver cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF2—liver cancer	2.72e-06	3.12e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A1—liver cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—liver cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—liver cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP2E1—liver cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A1—liver cancer	2.7e-06	3.09e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CB—liver cancer	2.63e-06	3e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CD—liver cancer	2.6e-06	2.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—liver cancer	2.58e-06	2.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—liver cancer	2.56e-06	2.93e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CD—liver cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CSF2—liver cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—liver cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYCS—liver cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—liver cancer	2.54e-06	2.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RAF1—liver cancer	2.54e-06	2.9e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—liver cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—liver cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HPGDS—liver cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—H2AFX—liver cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GOT1—liver cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GGT1—liver cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARA—liver cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—liver cancer	2.48e-06	2.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CB—liver cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—liver cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARA—liver cancer	2.47e-06	2.82e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.46e-06	2.81e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—liver cancer	2.42e-06	2.77e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLUL—liver cancer	2.4e-06	2.75e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CPT1B—liver cancer	2.4e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CD—liver cancer	2.4e-06	2.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—liver cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—liver cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—liver cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—liver cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—liver cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—liver cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RAF1—liver cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NR1H4—liver cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA3—liver cancer	2.28e-06	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—liver cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—liver cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAF1—liver cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—liver cancer	2.27e-06	2.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—liver cancer	2.26e-06	2.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—liver cancer	2.26e-06	2.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—liver cancer	2.26e-06	2.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMA4—liver cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMD10—liver cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—liver cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—liver cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—liver cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—liver cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—liver cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—liver cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GOT2—liver cancer	2.18e-06	2.49e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—liver cancer	2.16e-06	2.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAF1—liver cancer	2.14e-06	2.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.14e-06	2.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—liver cancer	2.13e-06	2.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—liver cancer	2.13e-06	2.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—liver cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—liver cancer	2.11e-06	2.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—liver cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—liver cancer	2.1e-06	2.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—liver cancer	2.1e-06	2.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—liver cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—liver cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA4—liver cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—liver cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—liver cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—liver cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—liver cancer	2.07e-06	2.36e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—liver cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK14—liver cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—liver cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—liver cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2E1—liver cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—liver cancer	2.04e-06	2.33e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—liver cancer	2.03e-06	2.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA2—liver cancer	2.03e-06	2.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—liver cancer	2.02e-06	2.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—liver cancer	2.02e-06	2.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—liver cancer	2.01e-06	2.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—F2—liver cancer	2e-06	2.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—liver cancer	1.97e-06	2.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—liver cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—liver cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA1—liver cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—liver cancer	1.95e-06	2.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAT2—liver cancer	1.94e-06	2.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—liver cancer	1.94e-06	2.21e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—liver cancer	1.92e-06	2.2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYCS—liver cancer	1.92e-06	2.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK8—liver cancer	1.91e-06	2.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—liver cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—liver cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—liver cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GGT1—liver cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GOT1—liver cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—liver cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—liver cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—liver cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—liver cancer	1.86e-06	2.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDOB—liver cancer	1.86e-06	2.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—liver cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—liver cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—liver cancer	1.83e-06	2.1e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—liver cancer	1.82e-06	2.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—liver cancer	1.81e-06	2.07e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—liver cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—liver cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARA—liver cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CRABP1—liver cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—liver cancer	1.75e-06	2e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—liver cancer	1.71e-06	1.96e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—liver cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—liver cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—liver cancer	1.67e-06	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—liver cancer	1.66e-06	1.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—liver cancer	1.64e-06	1.88e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—liver cancer	1.63e-06	1.87e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—liver cancer	1.62e-06	1.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—liver cancer	1.62e-06	1.85e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—liver cancer	1.6e-06	1.83e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—liver cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—liver cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—liver cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HPGDS—liver cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—liver cancer	1.53e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—liver cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—liver cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—liver cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAF1—liver cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—liver cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—liver cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—liver cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—liver cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—liver cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—liver cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—liver cancer	1.4e-06	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—liver cancer	1.39e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMD10—liver cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMA4—liver cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—liver cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—liver cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—liver cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—liver cancer	1.35e-06	1.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARA—liver cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—liver cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—liver cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—liver cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GOT2—liver cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—liver cancer	1.34e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—liver cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—liver cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—liver cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—liver cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—liver cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—liver cancer	1.28e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—liver cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—liver cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—liver cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2E1—liver cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—liver cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK8—liver cancer	1.24e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—liver cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—liver cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—liver cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYCS—liver cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—liver cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—liver cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GGT1—liver cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GOT1—liver cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—liver cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—liver cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—liver cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—liver cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—liver cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—liver cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—liver cancer	1.11e-06	1.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—liver cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—liver cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—liver cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—liver cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—liver cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—liver cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—liver cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—liver cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—liver cancer	1e-06	1.14e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—liver cancer	9.96e-07	1.14e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—liver cancer	9.87e-07	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—liver cancer	9.71e-07	1.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—liver cancer	9.57e-07	1.09e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—liver cancer	9.25e-07	1.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—liver cancer	9.07e-07	1.04e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—liver cancer	8.95e-07	1.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—liver cancer	8.92e-07	1.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—liver cancer	8.84e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—liver cancer	8.63e-07	9.87e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—liver cancer	8.46e-07	9.67e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARA—liver cancer	8.3e-07	9.49e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—liver cancer	8.26e-07	9.44e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—liver cancer	8.14e-07	9.31e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—liver cancer	8.07e-07	9.23e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—liver cancer	7.9e-07	9.04e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—liver cancer	7.29e-07	8.34e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—liver cancer	7.14e-07	8.16e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—liver cancer	7.1e-07	8.12e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—liver cancer	6.86e-07	7.84e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—liver cancer	6.25e-07	7.14e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—liver cancer	6.16e-07	7.05e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—liver cancer	5.83e-07	6.67e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—liver cancer	5.44e-07	6.23e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—liver cancer	5.39e-07	6.16e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—liver cancer	4.4e-07	5.03e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—liver cancer	3.32e-07	3.8e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—liver cancer	2.71e-07	3.1e-06	CbGpPWpGaD
